Effects of Long Biliopancreatic Limb vs. Long Alimentary Limb in Superobesity, a Randomized Study
- Conditions
- Morbid ObesityWeight Loss
- Interventions
- Procedure: gastric bypass
- Registration Number
- NCT01514799
- Lead Sponsor
- Aleris Obesity
- Brief Summary
Super Obesity, i.e. a BMI above 50, is difficult to treat. Normal gastric bypass surgery is not always enough for proper weight control. Bypassing a longer segment of the gut may be more beneficial. Which part to bypass is not clear.
The investigators want to compare the effects between preventing a 60 cm proximal (oral) portion of the jejunum from food contact with the effects when preventing a 200 cm part of the jejunum from contact with bile and pancreatic juice.
Endpoints are quality of life, gastrointestinal function, and weight development.
- Detailed Description
Two variations of gastric bypass are compared:
Method 1 (test method):A 200 cm BP-limb (distance Treitz to EA) + 150 cm common channel (EA to ileocecal valve) + Roux-Y-limb variable Method 2 (standard method): A 60 cm BP limb + 150 cm Roux-Y-limb + common channel variable.
Patients are evaluated according to the principles of the Scandinavian Obesity surgery registry (SOReg) with the addition of two additional questionnaires.
FU time is set at 5 years.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 140
- BMI 50-65
- Age 18-55
- Conservative attempts at weight reduction failed
- Inability to speak and understand the Swedish language
- Residence outside the county of Skåne
- Psychotic disease
- Inflammatory bowel disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Long BP limb gastric bypass 200 cm BP limb standard length bp limb, long alimentary limb gastric bypass our normal way of doing a gastric bypass 60 cm BP limb
- Primary Outcome Measures
Name Time Method body weight reduction 5 years absolute BW reduction, percentage of patients reaching BMI below 30,
- Secondary Outcome Measures
Name Time Method gastrointestinal function 5 years SF-36, Op-9, GSRS and TFEQ are used in patient assessed variables
Trial Locations
- Locations (1)
Aleris Obesity Skåne
🇸🇪Lund, Sweden